| Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979) |
|---|
| 04/22/2010 | WO2010043052A1 Azetidine derivatives as inhibitors of stearoyl-coenzyme a delta-9 desaturase |
| 04/22/2010 | WO2010012797A3 Synthesis of 3,4-diaryl-4,5-dihydro-(1h)-pyrazole-1- carboxamidine derivatives |
| 04/22/2010 | WO2010012466A8 Antitumor properties of no modified protease inhibitors |
| 04/22/2010 | WO2010012442A3 Insecticidal benzenedicarboxamide derivative |
| 04/22/2010 | WO2010011325A3 Synthesis and utilization of small molecules for the treatment of inflammation associated with interleukin-1 signaling |
| 04/22/2010 | WO2010008739A3 Aryl gpr119 agonists and uses thereof |
| 04/22/2010 | WO2009151561A3 Methods and compounds for antimicrobial intervention |
| 04/22/2010 | WO2009111679A3 Process |
| 04/22/2010 | WO2009095773A3 Novel heterocycles |
| 04/22/2010 | WO2009068468A3 Pyridine compounds |
| 04/22/2010 | WO2009034546A3 Trans-decahydroisoquinoline derivatives |
| 04/22/2010 | US20100099882 Process for the preparation of a benzimidazole derivative |
| 04/22/2010 | US20100099881 Sphingosine compound, method for producing the same, and sphingomyelinase inhibitor |
| 04/22/2010 | US20100099871 Anti-psychotic compounds and pharmaceutical compositions thereof |
| 04/22/2010 | US20100099718 Pyridine derivative substituted by heteroaryl ring, and antifungal agent comprising the same |
| 04/22/2010 | US20100099715 1,4-disubstituted 3-cyano-pyridone derivatives and their use as positive mglur2-receptor modulators |
| 04/22/2010 | US20100099712 Substituted pyrazoline compounds with acat inhibition activity |
| 04/22/2010 | US20100099708 Piperidine Derivative Used for Treating Chemokine Receptor 5 Mediated Diseases |
| 04/22/2010 | US20100099703 Phenylamino-substituted piperidine compounds, their preparation and use as medicaments |
| 04/22/2010 | US20100099694 2-anilino-4-heteroaryl pyrimidine derivatives, and preparation thereof as medicaments, pharmaceutical compositions, and in particular ikk inhibitors |
| 04/22/2010 | US20100099689 Methods of modulating ppar gamma-type receptors |
| 04/22/2010 | US20100099684 Quinuclidine Compounds as Alpha-7 Nicotinic Acetylcholine Receptor Ligands |
| 04/22/2010 | US20100099676 Sulfonylurea derivative capable of selectively inhibiting mmp-13 |
| 04/22/2010 | US20100099675 Novel pyrrole derivative having ureido group and aminocarbonyl group as substituents |
| 04/22/2010 | US20100099674 Method and means for preventing and inhibiting type iii secretion in infections caused by gram-negative bacteria |
| 04/22/2010 | US20100099673 Decahydroquinoline analogs as cb2 receptor modulators, useful in the treatment of pain, respiratory and non-respiratory diseases |
| 04/22/2010 | US20100099665 Isoquinolinone derivatives |
| 04/22/2010 | US20100099662 Hydrazone derivative |
| 04/22/2010 | US20100099659 Inhibitors of Bruton's Tyrosine Kinase |
| 04/22/2010 | US20100099077 Stable acridinium esters with fast light emission |
| 04/22/2010 | US20100098661 4,5-ring annulated indole derivatives for treating or preventing of hcv and related viral infections |
| 04/22/2010 | US20100098634 Imaging Agents Useful for Identifying AD Pathology |
| 04/22/2010 | US20100098631 Novel-2-Heteroaryl Substituted Indoles 695 |
| 04/22/2010 | CA2740608A1 Pesticidal (hetero) arylpyrrolidines |
| 04/22/2010 | CA2740333A1 Process for the preparation of enantiomerically enriched proton pump inhibitors |
| 04/22/2010 | CA2739491A1 Azine derivatives and methods of use thereof |
| 04/22/2010 | CA2739466A1 Azetidine derivatives as inhibitors of stearoyl-coenzyme a delta-9 desaturase |
| 04/22/2010 | CA2739344A1 Phenethylamide derivatives and their heterocyclic analogues |
| 04/22/2010 | CA2739058A1 Fused heterocyclic derivative and use thereof for medical purposes |
| 04/22/2010 | CA2738929A1 Heteroaryl substituted indole compounds useful as mmp-13 inhibitors |
| 04/22/2010 | CA2738806A1 Nicotinic acetylcholine receptor ligands and the uses thereof |
| 04/22/2010 | CA2738609A1 Piperidine compounds, pharmaceutical composition comprising the same and its use |
| 04/21/2010 | EP2177520A1 1,5-Di(aryl or heteroaryl)-3-halo-2(1H)-pyridones as intermediates for the preparation of AMPA receptor inhibitors |
| 04/21/2010 | EP2177519A1 Tetrazoyloxime derivative and plant disease control agent |
| 04/21/2010 | EP2177518A1 Organic compounds |
| 04/21/2010 | EP2177517A1 Amino substituted 2-(2,6-dioxopiperidin-3-yl)-phthalimide for reducing TNF alpha levels |
| 04/21/2010 | EP2177512A1 Inhibitor of binding of s1p1 |
| 04/21/2010 | EP2177511A2 Process for preparing 3,6-disubstituted azabicyclo derivatives |
| 04/21/2010 | EP2176251A2 5-pyridinone substituted indazoles |
| 04/21/2010 | EP2176250A1 Substituted heteroarylpiperidine derivatives as melanocortin-4 receptor modulators |
| 04/21/2010 | EP2176249A2 New chemical compounds |
| 04/21/2010 | EP2176237A1 Phthalazinone derivatives as inhibitors of parp-1 |
| 04/21/2010 | EP2176219A1 Novel compounds as cannabinoid receptor ligands |
| 04/21/2010 | EP1818329B1 (s)-(-)-1-(4-fluoroisoquinolin-5-yl)sulfonyl-2methyl-1,4homopiperazine hydrochloride dihydrate |
| 04/21/2010 | EP1761494B1 Chemical compounds i |
| 04/21/2010 | EP1479670B1 Novel fused ring indazole compounds |
| 04/21/2010 | EP1258252B1 Integrin expression inhibitors |
| 04/21/2010 | EP0888303B1 Synthetic derivatives of rapamycin as multimerizing agents for chimeric proteins with immunophilin-derived domains |
| 04/21/2010 | CN1854134B Piperazine compounds, their preparation method and pharmaceutical composition containing same |
| 04/21/2010 | CN1740169B Arylmethylamine derivatives for use as tryptase inhibitors |
| 04/21/2010 | CN1522246B Triamide-substituted indoles, benzofuranes and benzothiophenes |
| 04/21/2010 | CN101696206A Method for synthesizing 1-deoxynojirimycin derivatives containing 1,2,3-triazole |
| 04/21/2010 | CN101696205A 3-(substituted xylylenimine-2-yl)-2,6-dioxopiperidine polymorph and pharmaceutical composition |
| 04/21/2010 | CN101412710B Omeprazole sodium compound and preparation thereof |
| 04/20/2010 | US7700794 Fluorous tagging compounds and methods of increasing the fluorous nature of compounds |
| 04/20/2010 | US7700778 Acylated piperidine derivatives as melanocortin-4 receptor agonists |
| 04/20/2010 | US7700772 Amino heterocyclic modulators of chemokine receptor activity |
| 04/20/2010 | US7700771 antiinflammatory agents; antiarthritic agents |
| 04/20/2010 | US7700638 Such as 7-(3-Chlorophenyl)-1-phenyl-5-trifluoromethylbenzimidazole; antianxiety agents; side effect reduction |
| 04/20/2010 | US7700631 Use of pyridine N-oxide analogs at doses which do not induce emesis |
| 04/20/2010 | US7700630 3-Quinolin-2-ylmethylene-3,4,5,6-terahydro[2,3']bipyridinyl; for therapy and prophylaxis of psychotic diseases, neurodegenerative diseases involving a dysfunction of the cholinergic system |
| 04/20/2010 | US7700628 Aromatic ether derivatives useful as thrombin inhibitors |
| 04/20/2010 | US7700610 Use of tyrosine kinase inhibitors for treating allergic diseases |
| 04/20/2010 | US7700604 (5S)-5-methyl-5-({[6-[2-(trifluoromethyl)pyrimidin-5-yl]-3,4-dihydroisoquinolin-2(1H)-yl]sulfonyl}methyl)imidazolidine-2,4-dione; asthma, rhinitis, chronic obstructive pulmonary diseases (COPD), arthritis (such as rheumatoid arthritis and osteoarthritis), atherosclerosis, cancer |
| 04/20/2010 | US7700603 Use in treatment of cardiovascular diseases, cognitive and neurodegenerative diseases, inhibitors of Human Immunodeficiency Virus, plasmepsins, cathepsin D and protozoal enzymes; 5-(3-(3-trifluoromethoxyphenyl)phenyl)-2,5-dimethyl-1,2,4-oxadiazinan-3-imine, for example |
| 04/20/2010 | US7700602 And beta-amyloid formation; Alzheimer's Disease; 2-amino-5-(4-fluoro-3-pyrimidin-5-ylphenyl)-5-(4-methoxy-3-methylphenyl)-3-methyl-3,5-dihydro-4H-imidazol-4-one |
| 04/20/2010 | US7700599 G protein coupled receptor inhibitors (Gpr38) such as 6-[(4-fluorophenyl)oxy]-N-methyl-N-(4-{[(3S)-3-methyl-1-piperazinyl]methyl}phenyl)-3-pyridinecarboxamide for treatment of gastric stasis in an enterally fed patient |
| 04/20/2010 | US7700598 Selected CGRP-antagonists, process for preparing them and their use as pharmaceutical compositions |
| 04/20/2010 | US7700594 mammalian Target Of Rapamycin (mTOR) kinase; for treatment of lymphoma or ovarian cancer |
| 04/20/2010 | US7700591 to prevent or treat inflammatory and immunoregulatory disorders and diseases, allergic diseases, atopic conditions including allergic rhinitis, dermatitis, conjunctivitis, and asthma, as well as autoimmune pathologies such as rheumatoid arthritis and atherosclerosis |
| 04/20/2010 | US7700589 Such as 4-(2-oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidine-1-carboxylic acid-{(R)-1-(3,4-diethyl-benzyl)-2-[4-(1-methyl-piperidin-4-yl)-piperazin-1-yl]-2-oxo-ethyl}-amide; calcitonin gene related peptide (CGRP); for treatment of migraines; radioimmunoassay |
| 04/20/2010 | US7700584 antitumor agents; viricides |
| 04/20/2010 | US7700552 Macrocyclic inhibitors of hepatitis C virus |
| 04/20/2010 | CA2510540C Triazole derivatives as inhibitors of 11-beta-hydroxysteroid dehydrogenase-1 |
| 04/20/2010 | CA2494067C Hetero biaryl derivatives as matrix metalloproteinase inhibitors |
| 04/20/2010 | CA2454485C Arthropodicidal anthranilamides |
| 04/20/2010 | CA2434370C Hydroxy-substituted n-alkoxy hindered amines and compositions stabilized therewith |
| 04/20/2010 | CA2361587C Methods and compositions to enhance white blood cell count |
| 04/20/2010 | CA2348741C Nitrosasted and nitrosylated nonsteroidal antiinflammatory compounds, comositions and methods of use |
| 04/15/2010 | WO2010042925A2 Compositions and methods for treating alcohol use disorders, pain and other diseases |
| 04/15/2010 | WO2010042867A2 Activators of human pyruvate kinase |
| 04/15/2010 | WO2010042785A1 Method of inducing negative chemotaxis |
| 04/15/2010 | WO2010042758A2 Oxazole-pyridazine-oxazole alpha-helix mimetic |
| 04/15/2010 | WO2010042489A2 Aminoquinoline derived heat shock protein 90 inhibitors, methods of preparing same, and methods for their use |
| 04/15/2010 | WO2010042473A1 Biaryl spiroaminooxazoline analogues as alpha2c adrenergic receptor modulators |
| 04/15/2010 | WO2010042445A1 Carbazole compounds and therapeutic uses of the compounds |
| 04/15/2010 | WO2010042347A1 Quinolizidinone m1 receptor positive allosteric modulators |
| 04/15/2010 | WO2010041748A1 Fluorene compound and use thereof for medical purposes |
| 04/15/2010 | WO2010041711A1 Isoquinoline derivative, and pde inhibitor comprising same as active ingredient |
| 04/15/2010 | WO2010041691A1 Optical recording medium containing metal complex of squarylium compound |